Advertisement

< Back to Article

Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized Controlled Trial

Fig 3

Secondary maternal outcomes: anemia and malaria.

The p-value for the interaction term depicts the p-value for differences in effect size between paucigravidae and multigravidae.

*Data given as the number of women with an event, the number of events/person-years of follow-up, and, in parentheses, the incidence rate per 100 person-years.

#Maternal plasmodium infection detected by PCR, microscopy, or RDT. RDT data considered only when women were symptomatic (febrile). To allow for comparison between study arms, the routine scheduled RDT data in the ISTp-DP arm were not included.

Hb, hemoglobin; IPTp-SP, intermittent preventive therapy in pregnancy with sulfadoxine-pyrimethamine; IRR, incidence rate ratio; ISTp-DP, intermittent screening and treatment in pregnancy with dihydroartemisinin-piperaquine; py, person-years; RR, relative risk.

Fig 3

doi: https://doi.org/10.1371/journal.pmed.1002124.g003